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ABSTRACT 
 
The relationship between obesity, blood lipids and oxidative stress was investigated in 200 participants. The 
Body Mass Index of the subjects were positively correlated with the percentage body fat, the systolic and 
diastolic blood pressure, the fasting blood glucose level, the oxidation of proteins and lipids as well as the 
concentrations of total and LDL cholesterol. On the other hand, the Body Mass Index was negatively correlated 
to sulhydryl and protein levels. Obese subjects also had significantly higher body fat (p<.001), waist 
circumference (p<.001), fasting blood glucose (p<.01) as well as systolic blood pressure (p<.05). Obesity, 
therefore, can be said to increase the oxidation of plasma proteins and lipids while reducing the antioxidant 
status as observed by the inverse relation between plasma sulfhydryl groups and the percentage body fat. This 
increase in oxidative stress can predispose obese people to illnesses such as cardiovascular diseases and diabetes 
mellitus. 
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INTRODUCTION 
 
Obesity is a state characterized by a relatively absolute excess fat stored in the adipose 
tissue. Fatty tissues are normally present in the organism in reasonable quantity that is 
proportional to the height of an individual. The exact measurement of these fatty tissues is 
difficult. As such, one can only be termed obese when overweight. Since it is difficult to 
determine the ideal weight of an individual, the body mass index (BMI) is being used to 
give an idea of what the ideal weight could be. The BMI is also referred to as the Quetelet 
index that is defined as weight/height2. Risk of obesity begins when the BMI is greater than 
25 kg/m2. 
Obesity is a risk factor for adult coronary heart disease and is in increasing order among 
young people and adults (McGill et al., 2002), and it is a principal causative factor of 
metabolic syndrome (Montague & O’Rahilly, 2000; Matsuzawa, Shimomura, Nakamura, 
Keno, Kotani, & Tokunaga, 1999; Spiegelman & Flier, 2001; Kahn & Flier, 2000; 
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Furukawa et al., 2004). The coexistence of these metabolic syndromes - hyperglycemia, 
dyslipidemia, and hypertension in the same individual is a growing medical problem in 
industrialized countries (Furukwa et al., 2004; Ford, Giles, & Dietz, 2002; Isoma, Almgren, 
& Tuomi, 2001; Grundy, Brewer, Cleeman, Smith, & Lenfant, 2004). It has been reported 
that obesity may induce systemic oxidative stress and that increased oxidative stress in 
accumulated fat is associated with dysregulation of adipocytokines and development of 
metabolic syndrome (Furukawa et al., 2004). 
The present study addresses the relationship between obesity, oxidative stress and 
dislipidemia. 
 
 
MATERIAL AND METHODS 
 
 
Study Population  
 
Two hundred healthy individuals of both sex with confirmed consent, aged between 19 and 
55 years, resident in Yaoundé, Cameroon and with a BMI between 18.5 and 35.5 kg/m2 
were recruited for the study and divided into two groups as follows: BMI ≥ 30 (30 
individuals), BMI < 30 (170 individuals).   
 
 
Anthropometric Measurements 
 
The subject height was determined with aid of an anthropometer (± 0.1 cm). The weight and 
body fat percentage were assessed using a clinical balance (TANITA, USA) (± 0.05 kg) and 
the BMI calculated (kg.m-2). Groups were formed according to the classification of WHO 
(1998).  
 
 
Physiological Measurements 
 
Arterial pressure (diastolic, systolic and cardiac frequency) were measured in a resting 
position using a wrist blood pressure monitor (BDM-1, AFK Germany).  
 
 
Plasma Analysis 
 
Plasma was prepared from blood samples collected from subjects in the morning after an 
overnight fast of 12 hours. Plasma glucose was determined using glucose test strips 
(Johnson and Johnson). Total cholesterol (CHOL), high-density lipoprotein-cholesterol 
(HDL-C), and triglycerides (TG) were measured enzymatically using standard enzymatic 
kits (Sigma diagnostics). Low-density lipoprotein-cholesterol (LDL-C) was estimated using 
the Friedwald, Levy and Fredrickson (1972) formula while total protein was estimated by 
applying the method of Gornall, Bardwill and David (1949). Oxidative stress markers such 
as thiol groups (Habeeb, 1972), carbonyl group (Levine, Garland, & Oliver, 1990), and 
malonaldehyde (Yagi, 1976) were also measured. 
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Oxidative stress markers were evaluated for 195 subjects because plasma level was not 
enough for their assay. 
 
 
Statistical Analysis 
 
The results are presented as a mean ± standard deviation. Differences between the groups 
were analysed using Student’s t-test. The Pearson product moment correlations were used to 
determine the relationships between variables. All calculations were done with SPSS 10.1 
(SSPS Inc., Chicago, IL, USA) statistical package. Statistical significance was defined at 
p<.05. 
 
 
RESULTS 
 
Anthropometric and physiological parameters of obese and overweight subjects compared to 
normal subjects are presented in Table 1. 
 
 
Table 1. Anthropometric and Physiological Parameters of  
Obese and Overweight Subjects Compared to Normal Subjects  
Parameters Normal Subjects 
(100) 
Overweight 
Subjects (65) 
Obese subjects 
N = (30) 
BMI (Kg/m2 22-25 26-30 > 30 
Body Fat (%) 23.27 ± 1.01 26.91 ±  0.91a 41.7 ±  1.10a 
Waist circumference 
(cm) 
77.27 ± 1.77 79.30 ±  1.41 97.27 ±  2.76a 
Systolic pressure 
(mmHg) 
123.69 ± 1.22 124.72± 0.99 129.13 ± 1.74a 
Diastolic pressure 
(mmHg) 
86.82 ± 1.26 87.13 ±11.64 88.27 ± 2.44 
Pulse rate (min-1) 76.40 ± 1.47 74.64 ± 1.03 77.03 ± 2.21 
a  significant p<.0001 
 
 
The percentage fat and waist circumference of the overweight and obese subjects were 
significantly higher (p<.0001) than those of the normal subjects. This high fat deposit is the 
cause for overweight and obesity. However, the physiological parameters such as diastolic 
and pulse rate were not statistically different between the three categories and the systolic 
pressure of the obese subjects was significantly higher (p<.0001) than that of the normal 
subjects.  
Table 2 compares the blood glucose and lipid parameter of the overweight and obese 
subjects with the normal subjects.  
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Table 2. Blood Glucose and Lipid Parameters of  
Overweight and Obese Subjects Compared to Normal Subjects 
Parameters Normal Subjects 
(n=100) 
Overweight 
Subjects (n=65) 
Obese Subjects 
(n=30) 
Blood glucose 
(mg/dl) 
78.46 ± 1.79 79.10 ± 1.40 91.75 ± 4.51a 
Total Cholesterol 
(mg/dl)  
112.73 ± 6.49 118.55 ± 4.94 138.27 ± 13.47 
LDL Cholesterol 
(mg/dl)  
65.86 ± 6.58 72.91 ± 5.05 92.79 ± 14.29 
HDL Cholesterol 
(mg/dl)  
32.70 ± 3.44 30.29 ± 2.13 25.66 ± 2.15 
Triglycerides (mg/dl) 89.41 ± 6.86 94.89 ± 5.38 93.79 ± 7.46 
a
 significant p<.001 
 
 
It was observed that only the blood glucose was significantly higher in the obese 
subjects than in the normal subjects though the glucose concentration was still within the 
normal range. No significant alternation was noticed in the lipid parameters.  
The oxidative stress markers of overweight and obese subjects compared to normal 
subjects are presented in Table 3.  
 
 
Table 3. Oxidative Stress Markers of Overweight and Obese Subjects  
Compared to Normal Subjects 
 Parameters Normal Subjects 
(n=100) 
Overweight 
Subjects (n=65) 
Obese Subjects 
(n=30) 
Sulfhydryl (µmol/g 
protein) 
0.64 ± 0.04 0.58 ± 0.033a 0.43 ± 0.047a 
Carbonyl (µmol/g 
protein) 
1.37 ± 0.63 1.59 ± 0.06b 2.22 ± 0.10b 
Malonaldehyde 
(µmol/l) 
0.08 ± 0.008 0.13 ± 0.014c 0.25 ± 0.037c 
Proteins (g/l) 59.11 ± 2.25 60.01 ± 1.90 51.34 ± 7.77 
a
 significant p<.05, b significant p<.0001, c significant p<.002 
 
 
Significant decrease in sulfhydryl groups (p<.0001), significant increase in carbonyl groups 
and malonaldehyde were observed in both the overweight and obese. This confirms the 
presence of oxidative stress in both the overweight and obese subjects. 
Sunway Academic Journal 5 153 
DISCUSSION 
 
The incidence of obesity in adults as well as children is on an increase globally. Once 
considered a problem of developed countries, this global epidemic also affects developing 
countries. Coupled with this epidemic are obesity-related complications such as 
cardiovascular disease, stroke, depression and Type-2 diabetes, which are spreading rapidly 
across poor and middle-income countries, where infectious diseases and malnutrition have 
previously overshadowed such illnesses (McGill et al., 2002). HDL-cholesterol corroborates 
earlier work that showed an inverse relation between BMI and HDL-cholesterol, the latter 
imparting possible health benefits in over-weight and obese people (Pietrobelli, Lee, 
Capristo, Deckelbaum, & Heymsfield, 1999; Knuiman, West, & Burema, 1982). The 
increase in the concentration of HDL-cholesterol and a decrease in the concentration of 
LDL-cholesterol could lead to a lowering of the atherogenicity and therefore a significant 
reduction in the potential incidence of coronary heart disease (Griffin, 1999) (54% reduction 
of risk for a 0.6 mmol/L reduction of serum cholesterol) (WHO, 1998). A reduction of 
fasting blood glucose levels as well as MDA levels have been previously reported to 
accompany weight loss in obese subjects (Yesilbursa, Serdar, Serdar, Sarac, & Jale, 2005). 
The above observation could be linked to an increase in circulating creatinine and serotonin 
over the 8-week trial period. Serotonin is known to have a positive effect on mood and to 
reduce binge eating, which is common in obese people. Several previous studies (Nelson, 
Day, Glickman-Weiss, Hegstad, & Sampson, 1997; Rockwell, Rankin, & Toderico, 2001) 
have shown a direct link between serotonin levels and weight loss. On the other hand, an 
increase in creatinine concentrations parallels an increase in lean muscle mass and a 
probable reduction in body fat.  
Obesity may induce systemic oxidative stress, and increased oxidative stress in 
accumulated fat is one of the underlying causes of dysregulation of adipocytokines and 
development of metabolic syndrome (Furukawa et al., 2004). Oxidative stress plays critical 
roles in the pathogenesis of various diseases (Brownlee, 2001). In order to investigate if 
oxidative stress was increased in the obese participants, we measured lipid peroxidation 
which represent the plasma Thiobarbituric acid reactive substances (TBARS) and the 
carbonyl compounds as markers of oxidative injury, which correlates with the BMI. The 
high plasma concentration of TBARS and carbonyl compounds was an indication of 
oxidative stress in the obese and overweight participants. 
In the diabetic condition, oxidative stress impairs glucose uptake in muscle and adipose 
tissue (Maddux, 2001; Rudich, 1998) and decreases insulin secretion from pancreatic ß cells 
(Matsuoka, 1997). Increased oxidative stress also underlies the pathophysiology of 
hypertension (Nakazono, 1991) and atherosclerosis (Ohara, Peterson, & Harrison, 1993) by 
directly affecting vascular cell walls. 
In the present study, we suggest that obesity per se may induce systemic oxidative stress 
and that increased oxidative stress in adipose tissue is, at least in part, the underlying cause 
of dysregulation of adipocytokines and development of metabolic syndrome. As an early 
indicator of obesity associated metabolic syndrome, increased oxidative stress in adipose 
tissue should be an important target for the development of new therapies. 
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